Company intelligence / Profile preview

Julius Clinical

Zeist, Utrecht, Netherlandsjuliusclinical.com ↗

Ownership: Private
Employees: ~176
Development stage: Commercial

Overview

Julius Clinical is a leading full-service CRO headquartered in Zeist, Netherlands. Founded in 2008, it specializes in managing global Phase I–III clinical trials with particular expertise in CNS, cardio-metabolic, renal and rare disease indications. The company has conducted over 380 clinical trials involving more than 220,000 subjects across at least 39 countries. In May 2025 it merged with Peachtree BioResearch Solutions to expand its international reach and deepen CNS capabilities. Supported by Ampersand Capital Partners since at least May 2025.

Therapeutic areas: Metabolic DisordersRare DiseasesNeurologyCardiovascularNephrologyInfectious Diseases
Modalities: Small moleculesBiologicsMedical devices
Industry: Contract Research Organization

Partnerships

Pharmaceutical companiesBiotechnology companiesMedical device companies

Beyond the preview

Go deeper on Julius Clinical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Julius Clinical.

Explore the full profile